Specific Cytotoxicity of a Novel Arbutin Derivative from Myrothamnus flabellifolius Against Human Leukemia Cells
Conclusion: The data from this study has led in establishing a novel arbutin derivative to be specifically cytotoxic to acute myeloid leukemia cells. This compound can be chemically modified and developed as a potential anti-leukemia drug.
Source: Research Journal of Medicinal Plant - Category: Complementary Medicine Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | African Health | Cancer | Cancer & Oncology | Chemistry | Complementary Medicine | Cough | Gingivitis | Herbs | Leukemia | Study | Urology & Nephrology